Starling Oncology Rebrands, Launches Tech Platform for Cancer Care
California-based Starling Oncology has rebranded from The Oncology Institute and launched a new technology platform, Starling Nexus™, to streamline prior authorizations and clinical decision-making.
Starling Oncology, formerly The Oncology Institute, has completed a company-wide rebrand and launched a new technology platform named Starling Nexus™. The initiative aims to enhance coordinated, high-quality cancer care delivered through its community-based clinics, particularly in Southern California.
The Starling Nexus™ platform is designed to accelerate prior authorization processes and support clinical decision-making. This technological advancement is intended to allow clinicians to dedicate more time to patient care by reducing administrative tasks. The company states this aligns with a broader organizational shift towards prioritizing measurable outcomes and care quality over treatment volume.
The rebrand signifies a strategic move for the organization, transitioning from a traditional oncology practice to an integrated care platform serving patients, providers, and health plans across multiple states. The new name, Starling Oncology, reflects its coordinated, team-based approach to care delivery.
Starling Oncology emphasizes delivering high-quality, outcomes-focused cancer treatment in community settings. Services include outpatient transfusions and access to clinical trials. The organization also holds a Patient Safety Organization designation, underscoring its structured, data-driven methodology for identifying and mitigating care risks within its network.